TrialsgrambetaRCTs are beautiful

PARTNER 1B

2010

Placement of Aortic Transcatheter Valves — cohort B (inoperable)

In 358 patients with severe AS deemed inoperable, transcatheter aortic-valve replacement reduced all-cause mortality at 1 year compared with medical therapy.

Result

Efficacy: All-cause mortalityHR 0.55

Below 1 favours transcatheter aortic-valve replacement, above 1 favours medical therapy.

Event rates
Absolute difference
20.0 points

The absolute difference is derived from the event rates.

Original publication
Subtopic
TAVR
Design
RCT, 1 yr
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Leon MB, et al. N Engl J Med. 2010;363(17):1597-1607.doi 10.1056/NEJMoa1008232

Discussion & critique

Vascular complications and stroke rates high in early TAVR; improved markedly in subsequent generations. Established TAVR for inoperable patients.